A – Agilent Technologies, Inc.
Agilent Technologies, Inc.A
$103.00Name : Agilent Technologies, Inc.
Sector : Healthcare
Industry: Diagnostics & Research
Mark. Cap: $29,365,610,496.00
EPSttm : 4.36
Agilent Technologies, Inc.
$103.00
6.08%$6.67Float Short %
1.38
Margin Of Safety %
24
Put/Call OI Ratio
0.86
EPS Next Q Diff
0.09
EPS Last/This Y
1.13
EPS This/Next Y
0.52
Price
102.97
Target Price
150.73
Analyst Recom
2.19
Performance Q
-22.81
Relative Volume
1.96
Beta
1.26
Ticker: A
of 1
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2025-03-07 | A | 126.68 | 0.88 | 17.88 | 31839 |
| 2025-03-10 | A | 121.92 | 0.96 | 3.79 | 33167 |
| 2025-03-11 | A | 121.03 | 0.93 | 11.20 | 32769 |
| 2025-03-12 | A | 119.95 | 0.88 | 7.34 | 32008 |
| 2025-03-13 | A | 117.31 | 0.81 | 5.91 | 30897 |
| 2025-03-14 | A | 121.22 | 0.79 | 1.02 | 30857 |
| 2025-03-17 | A | 122.51 | 0.79 | 0.15 | 31563 |
| 2025-03-18 | A | 123.12 | 0.78 | 0.58 | 31926 |
| 2025-03-19 | A | 122.23 | 0.78 | 0.15 | 32515 |
| 2025-03-20 | A | 120.28 | 0.76 | 21.75 | 32912 |
| 2025-03-21 | A | 120.7 | 0.66 | 2.18 | 31066 |
| 2025-03-24 | A | 121.96 | 0.90 | 0.74 | 19755 |
| 2025-03-25 | A | 120.5 | 0.88 | 0.84 | 19944 |
| 2025-03-26 | A | 119.9 | 0.89 | 1.05 | 20776 |
| 2025-03-27 | A | 119 | 0.88 | 0.94 | 21389 |
| 2025-03-28 | A | 116.71 | 0.89 | 0.93 | 21757 |
| 2025-03-31 | A | 116.97 | 0.89 | 0.93 | 21900 |
| 2025-04-01 | A | 114.05 | 0.86 | 2.39 | 23209 |
| 2025-04-02 | A | 115.98 | 0.81 | 3.32 | 22730 |
| 2025-04-03 | A | 109.68 | 0.81 | 8.50 | 22932 |
| 2025-04-04 | A | 102.96 | 0.86 | 0.49 | 23895 |
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2025-03-07 | A | 126.66 | 4.0 | 136.3 | 5.57 |
| 2025-03-10 | A | 121.92 | 4.0 | 73.2 | 5.57 |
| 2025-03-11 | A | 121.03 | 4.0 | 123.2 | 5.57 |
| 2025-03-12 | A | 119.91 | 4.0 | 119.7 | 5.57 |
| 2025-03-13 | A | 117.31 | 4.0 | 100.3 | 5.57 |
| 2025-03-14 | A | 121.18 | 4.0 | 188.4 | 5.57 |
| 2025-03-17 | A | 122.49 | 4.0 | 152.5 | 5.57 |
| 2025-03-18 | A | 123.12 | 4.0 | 143.3 | 5.57 |
| 2025-03-19 | A | 122.21 | 4.0 | 123.1 | 5.57 |
| 2025-03-20 | A | 120.28 | 4.0 | 109.1 | 5.57 |
| 2025-03-21 | A | 120.77 | 4.0 | 141.5 | 5.57 |
| 2025-03-24 | A | 121.97 | 4.0 | 151.4 | 5.57 |
| 2025-03-25 | A | 120.51 | 4.0 | 115.3 | 5.57 |
| 2025-03-26 | A | 119.90 | 4.0 | 126.6 | 5.57 |
| 2025-03-27 | A | 118.96 | 4.0 | 122.1 | 5.57 |
| 2025-03-28 | A | 116.69 | 4.0 | 103.6 | 5.57 |
| 2025-03-31 | A | 116.88 | 4.0 | 137.5 | 5.57 |
| 2025-04-01 | A | 114.05 | 4.0 | 94.1 | 5.57 |
| 2025-04-02 | A | 115.99 | 4.0 | 162.5 | 5.57 |
| 2025-04-03 | A | 109.64 | 4.0 | 45.7 | 5.57 |
| 2025-04-04 | A | 102.97 | 4.1 | 38.9 | 5.57 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2025-03-07 | A | -1.28 | -0.16 | 1.04 |
| 2025-03-10 | A | -1.79 | 0.16 | 1.04 |
| 2025-03-11 | A | -1.79 | 0.16 | 1.04 |
| 2025-03-12 | A | -1.79 | 0.16 | 1.21 |
| 2025-03-13 | A | -1.79 | 0.16 | 1.21 |
| 2025-03-14 | A | -1.79 | 0.16 | 1.21 |
| 2025-03-17 | A | -1.96 | 0.17 | 1.21 |
| 2025-03-18 | A | -2.27 | 0.17 | 1.21 |
| 2025-03-19 | A | -2.27 | 0.17 | 1.21 |
| 2025-03-20 | A | -2.27 | 0.17 | 1.21 |
| 2025-03-21 | A | -2.27 | 0.17 | 1.21 |
| 2025-03-24 | A | -2.27 | 0.22 | 1.21 |
| 2025-03-25 | A | -2.27 | 0.22 | 1.21 |
| 2025-03-26 | A | -2.27 | 0.22 | 1.38 |
| 2025-03-27 | A | -2.27 | 0.22 | 1.38 |
| 2025-03-28 | A | -0.97 | 0.22 | 1.38 |
| 2025-03-31 | A | -0.97 | 0.20 | 1.38 |
| 2025-04-01 | A | -0.96 | 0.20 | 1.38 |
| 2025-04-02 | A | -1.12 | 0.20 | 1.38 |
| 2025-04-03 | A | -1.12 | 0.20 | 1.38 |
| 2025-04-04 | A | -1.12 | 0.20 | 1.38 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
1.31
Avg. EPS Est. Current Quarter
1.27
Avg. EPS Est. Next Quarter
1.4
Insider Transactions
-1.12
Institutional Transactions
0.2
Beta
1.26
Average Sales Estimate Current Quarter
1628
Average Sales Estimate Next Quarter
1648
Fair Value
128.01
Quality Score
94
Growth Score
79
Sentiment Score
10
Actual DrawDown %
42.7
Max Drawdown 5-Year %
-42.7
Target Price
150.73
P/E
23.67
Forward P/E
16.89
PEG
2.88
P/S
4.49
P/B
4.87
P/Free Cash Flow
22.38
EPS
4.35
Average EPS Est. Cur. Y
5.57
EPS Next Y. (Est.)
6.09
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
19.27
Relative Volume
1.96
Return on Equity vs Sector %
1.1
Return on Equity vs Industry %
10.1
EPS 1 7Days Diff
EPS 1 30Days Diff
EBIT Estimation
38.9
Agilent Technologies, Inc.Sector: Healthcare
Industry: Diagnostics & Research
Employees: 17900
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies. This segment also offers GC and LC columns, sample preparation products, custom chemistries, and laboratory instrument supplies. The Diagnostics and Genomics segment provides genomics, contract manufacturing and research and development, pathology, companion diagnostics, reagent partnership, and biomolecular analysis businesses; and cell analysis plate based assays, flow cytometers, real-time cell analyzers, cell imaging systems, microplate readers, and related consumables. The Agilent CrossLab segment provides various services, including repairs, parts, maintenance, installations, training, compliance support, software as a service, asset management, and consulting services. The company markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.
stock quote shares A – Agilent Technologies, Inc. Stock Price stock today
news today A – Agilent Technologies, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch A – Agilent Technologies, Inc. yahoo finance google finance
stock history A – Agilent Technologies, Inc. invest stock market
stock prices A premarket after hours
ticker A fair value insiders trading